Delivery Order SPE2DB22D3004-SPE2DB25FPS28

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,801.80, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 21, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,902.93, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 14, 2024. The contract is not designated with a set-aside requirement, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,612.60, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 10, 2025. This award is not associated with a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,612.52, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order under a Firm Fixed Price arrangement, with a completion date of February 8, 2024. It does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,448.38, is a delivery order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a firm fixed price and an ultimate completion date of February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,939.08, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,561.83, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 4, 2024. There is no set-aside designation for this award. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,003.00 firm fixed-price delivery order is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,961.16, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of January 16, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,351.35, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 29, 2025. This award does not have a set-aside designation, indicating...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPS28
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,953.19, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. It is a firm fixed-price delivery order contract with a completion date of February 27, 2025. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/28/25, 10:42 AM